Safety-Related Labeling Changes

Use in Patients with congenital or acquired QT prolongation. Interactions with Potent CYP2D6 Inhibitors and Potent CYP3A4 Inhibitors

Trade Name

Detrusitol

Updated Section

4.4 Special warnings and precautions for use. 4.5 Interactions with other medicinal products

Month

Nov,2024